We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer.
- Authors
Koutras, Angelos K.; Mastronikolis, Nicholas S.; Jeffry Evans, Tr; Papadeas, Evangelos S.; Makatsoris, Thomas; Kalofonos, Haralabos P.
- Abstract
A letter to the editor is presented that discusses ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer.
- Subjects
LETTERS to the editor; OTOTOXICITY; DRUG side effects; PANCREATIC cancer treatment; PROTEIN-tyrosine kinase inhibitors; DRUG toxicity; SKIN inflammation; DIARRHEA; THERAPEUTICS
- Publication
Acta Oncologica, 2008, Vol 47, Issue 6, p1171
- ISSN
0284-186X
- Publication type
Article
- DOI
10.1080/02841860802213328